Your basket is currently empty!
Vaccine Shows Promise in Early Trial
Kidney Cancer Vaccine Shows Promise in Early Trial The vaccine generated robust immune response in nine patients with advanced disease All patients remained cancer-free for an average of 3 years. The findings remain to be replicated in larger studies. In a small...